A new antibacterial agent that has been engineered to essentially hide from the human immune system may treat life-threatening MRSA infections. A new article provides details on the agent, which is the first lysin-based treatment with the potential to be used multiple times on a single patient, making it ideal to treat particularly persistent drug-resistant and drug-sensitive infections.
from Latest Science News -- ScienceDaily https://ift.tt/3jDgoDR
No comments:
Post a Comment